Kelsey Taylor Resnicow
Program Director, Dapirolizumab Pegol, Product Development & Commercialization @Biogen
Boston, MA, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Feb 2025 — Present
Program Director, Dapirolizumab Pegol, Product Development & Commercialization @Biogen
View department →
Cambridge, MA, US
Leading and supporting key development and commercial strategic projects for Biogen/UCB partnered Phase 3 program for systemic lupus
EDUCATION
N/A
Connecticut College
Bachelor of Arts (B.A.), Biochemistry and Molecular Biology
2016
Harvard University
Doctor of Philosophy (Ph.D.), Biological and Biomedical Sciences
ABOUT KELSEY TAYLOR RESNICOW
Program Director, Lupus Product Development & Commercialization
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.